Literature DB >> 8000654

Hepatic resection for hepatolithiasis and long-term results.

K Chijiiwa1, N Kameoka, M Komura, T Yamasaki, H Noshiro, K Nakano.   

Abstract

BACKGROUND: Hepatic resection is an established procedure for treating patients with hepatolithiasis. The long-term results after hepatic resection for hepatolithiasis were appraised. STUDY
DESIGN: Of 127 patients with hepatolithiasis seen between 1973 and 1993, 43 patients underwent hepatic resection, and constituted the basis of this study.
RESULTS: There was one operative death (operative mortality rate of 2.3 percent) and three deaths as a result of concomitantly associated cholangiocellular carcinoma. Of the remaining 39 patients, the complete stone clearance rate was 67 percent with operation alone, but reached 87 percent when cholangioscopy was used. Operative morbidity was recorded in five patients (12 percent), but they recovered with conservative therapy. Stones recurred in 15 percent of patients after a mean follow-up period of four years (range of three to six years). Eleven (28 percent) of 39 patients died after hepatectomy as a result of related diseases after a mean follow-up of 6.2 years. These 11 patients had associated biliary drainage procedures. They experienced a higher mortality rate (p < 0.05) than patients who did not have biliary drainage.
CONCLUSIONS: We conclude that hepatic resection is adequate treatment for hepatolithiasis. The patients having additional biliary drainage procedures had a higher mortality, but one cannot reach conclusions about the negative effect of the drainage procedures because the drainage procedures were done in a selected and not a randomized manner.

Entities:  

Mesh:

Year:  1995        PMID: 8000654

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  9 in total

1.  Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis.

Authors:  Chang-Ku Jia; Jie Weng; You-Ke Chen; Qing-Zhuang Yang; Yu Fu; Qi-Fan Qin; Wei-Ming Yu
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  A preliminary study of applying chemical biliary duct embolization to chemical hepatectomy in rats.

Authors:  Fu Yu Li; Jing Qiu Cheng; Sheng He; Ning Li; Ming Ming Zhang; Jia Hong Dong; Li Sheng Jiang; Nan Sheng Cheng; Xian Zhe Xiong
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

3.  Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis.

Authors:  Bong-Wan Kim; Hee-Jung Wang; Wook-Hwan Kim; Myung-Wook Kim
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Left-sided hepatic resection for hepatolithiasis: a longitudinal study of 110 patients.

Authors:  Omar Javed Shah; Irfan Robbani; Parveen Shah; Showkat Ali Zargar; Gul Javaid; Ghulam N Yattoo; Altaf Shah; Farhat Mustafa
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

5.  Treatment of non-endemic hepatolithiasis in a Western country. The role of hepatic resection.

Authors:  Marco Catena; Luca Aldrighetti; Renato Finazzi; Giandomenico Arzu; Marcella Arru; Carlo Pulitanò; Gianfranco Ferla
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

6.  Non-Oriental primary intrahepatic lithiasis: experience with 48 cases.

Authors:  Paulo Herman; Telesforo Bacchella; Vincenzo Pugliese; André L Montagnini; Marcel Autran C Machado; José Eduardo M da Cunha; Marcel C C Machado
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

7.  Selection of surgical treatment types for intrahepatic duct stones.

Authors:  Kyung Sook Hong; Kyoung Tae Noh; Seog Ki Min; Hyeon Kook Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-08-31

8.  Does bilioenteric anastomosis impair results of liver resection in primary intrahepatic lithiasis?

Authors:  Paulo Herman; Marcos V Perini; Vincenzo Pugliese; Julio Cesar Pereira; Marcel Autran C Machado; William A Saad; Luiz A C D'Albuquerque; Ivan Cecconello
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

9.  Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target.

Authors:  Ming-Shian Tsai; Po-Huang Lee; Cheuk-Kwan Sun; Ting-Chia Chiu; Yu-Chun Lin; I-Wei Chang; Po-Han Chen; Ying-Hsien Kao
Journal:  Exp Mol Med       Date:  2018-01-12       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.